VIRTUAL: Ocular Gene Therapy: It’s not just for inherited retinal disease featuring Timothy Stout, MD

8:00 pm Presentation

Ocular Gene Therapy: It’s not just for inherited retinal disease

J. Timothy Stout, MD

Director-Cullen Eye Institute and Chair-Department of Ophthalmology
Baylor College of Medicine
Houston, TX US

Education

MD from Baylor College of Medicine

Houston, Texas United States

PhD from Baylor College of Medicine

Houston, Texas United States

Molecular Genetics

Internship at Baylor College of Medicine

Houston, TX

Pediatrics

Residency at University of Southern California - Doheny Eye Institute

Los Angeles, CA

Ophthalmology

Fellowship at Moorfields Eye Hospital

London, England

Medical Retina

Fellowship at University of Southern California - Doheny Eye Institute

Los Angeles, CA

Surgical Retina

MBA from University of Oregon

Portland, Oregon United States

Certifications

American Board of Ophthalmology

Professional Interests

• Pediatric Vitreoretinal Diseases and Surgery
• Genetics and Stem Cell Therapy

Professional Statement

Dr. Stout has been the Sid W. Richardson Professor and Margarett Root Brown Chair of the Department of Ophthalmology, and Director of the Cullen Eye Institute at Baylor College of Medicine since 2013. Prior to that he served as Professor in the Departments of Ophthalmology and Molecular Genetics, as well as Vice President for Commercialization Strategies at Oregon Health & Science University in Portland, Oregon. He has directed the Clayton Gene Therapy Laboratories since 1995.

Dr. Stout brings experience from both the research and clinical sides of medicine. His research interests include human gene and cell-based therapy for proliferative and inherited ocular disease, retinal disease genotype-phenotype correlation and ocular disease gene mapping and discovery.

Educational Objectives:
Following this presentation, the participant should be able to:

• To better understand the current landscape of gene transfer into ocular tissue.   
• To better understand how this may benefit diseases other than inherited retinal diseases.

ACCREDITATION STATEMENT This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Minnesota Medical Association and University of Minnesota, Department of Ophthalmology. The Minnesota Medical Association (MMA) is accredited by the ACCME to provide continuing medical education for physicians.    

CME STATEMENT The Minnesota Medical Association designates this Regularly Scheduled Series for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Thank you to our Exhibitors:

Genentech

Regeneron